services in Q2/2019 were THB 44 million decreased by 8% in comparison with the same period at the previous year. 2 In 2Q/2019, the Company has loss of THB 85 million, increased loss by 78% comparing to the

that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of

15% and increased by 29% compared to Q2/2019 and Q1/2019, respectively. The Company and its subsidiary companies made a loss of THB 56 million in Q3/2019 or loss increased by 73% compared to the same

measurement of the government. In 2Q/2020, the Company has net profit during the period of THB 0.96 million, increased by 101% comparing to the same period at the previous year. The main reason is due to the

[COMPANY NAME] Ref.:EFORL020/2018 May 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 31 March 2018 To President The Stock Exchange of Thailand 1. Overview financial

[COMPANY NAME] Ref.: EFORL IR008/2019 March 7, 2019 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2018 To President The Stock Exchange of Thailand 1. Overview financial

[COMPANY NAME] Ref.: EFORL IR 037/2018 August 15, 2018 Subject: Notification of allocation and subscription of capital increase ordinary shares of WCI Holding Public Company Limited. (Edit) To: The

construction contract to construction in progress as significant. Liabilities As at September 30, 2018, the Company and its subsidiaries had total liabilities of Baht 3,600.78 million increased from Baht

31, 2019 As at December 31, 2018 increase (decrease) Assets As at March 31, 2019, the Company and its subsidiaries had total assets of Baht 7,531.89 million increased from as of December 31, 2018 which

Assets As of June 30, 2020, the Company and its subsidiaries had total assets of Baht 8,905.86. million increased from Baht 8,553.07 million as of December 31, 2019 of Baht 352.79 million or 4.12